BROSSARD, QUEBEC--(Marketwired - Feb. 12, 2014) - Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in healthcare technical services including, screening, software and algorithm development, data analysis, and image processing, announced today the signing of a Contract with California-based Chaparral Medical Group for the deployment and usage of CARA, for diabetic retinopathy screening platform in that state.
Chaparral Medical Group is a well established multi-speciality physician group with multiple clinics in California that has decided to increase the scope of services they offer to their patients by integrating a CARA-enabled fundus camera, and DIAGNOS support, into their practice. Chaparral serves a total of 10,000 patients suffering from diabetes in their network and views this camera as the beginning of a larger project that will ultimately encompass all of their patients who require annual retinal screening. The camera has been deployed in an endocrinology clinic in Pomona, CA, where DIAGNOS has trained local staff to perform screening exams and use DIAGNOS' tele-opthalmology platform.
"This is DIAGNOS' first deployment of this type in the United States and we are very excited by increases in demand for our screening services and software tools. We look forward to the successful launch and operation of this project, and to future deployments within the United States," said André Larente, DIAGNOS' President.
About Chaparral Medical Group
Chaparral Medical Group is a 60 physician multi-specialty group serving the communities of Claremont, La Verne, San Dimas, Fontana, Pomona, Rancho Cucamonga, Upland, Chino Hills and Diamond Bar in Southern California. Over 20 primary care physicians serve as the group's clinical core, and work together with their medical and surgical specialists to provide outstanding care to the patient population Southeastern California. They have been serving the community since 1978 and their unwavering commitment to patient care and physician work satisfaction are what have driven them to become the most trusted and relied-upon group of physicians in their area.
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare and natural resources.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information on DIAGNOS, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.